# Abuse Potential of HORIZANT With and Without Oxycodone in Healthy, Nondependent Recreational Opioid Users

> **NCT06247488** · PHASE4 · COMPLETED · sponsor: **Arbor Pharmaceuticals, Inc.** · enrollment: 110 (actual)

## Conditions studied

- Abuse Potential

## Interventions

- **DRUG:** Placebo
- **DRUG:** Oxycodone 20 mg
- **DRUG:** GE-IR 200 mg
- **DRUG:** GE-IR 450 mg

## Key facts

- **NCT ID:** NCT06247488
- **Lead sponsor:** Arbor Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-31
- **Primary completion:** 2023-04-25
- **Final completion:** 2023-04-25
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2024-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06247488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06247488, "Abuse Potential of HORIZANT With and Without Oxycodone in Healthy, Nondependent Recreational Opioid Users". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06247488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*